Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K(ATP)) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. METHODS: We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. RESULTS: Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K(ATP) channels was greatly reduced. CONCLUSIONS: Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“can be treated with high-dose sulfonylureas despite being insulin dependent also provide a compelling case for genetic evaluation of monogenic diabetes with therapeutic and prognostic implications ( 2 – 6 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings that neonatal diabetes is most commonly due to activating mutations in genes encoding the ATP-sensitive potassium channel subunits Kir6.2 or SUR1”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
Cross sectional stature and weight reference curves for the UK, 1990.
Freeman, J. V., Cole, T. J., Chinn, S., Jones, P. R., White, E. M., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.17 · Cited by 1,457
Stoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng0197-106 · Cited by 1,106
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State
Kuo, A., Gulbis, J. M., Antcliff, J. F., Rahman, T., Lowe, E. D., Zimmer, J., Cuthbertson, J., Ashcroft, F. M., Ezaki, T., & Doyle, D. A. (2003) · Science · doi:10.1126/science.1085028 · Cited by 785
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Self-citationAssociation and Stoichiometry of KATP Channel Subunits
Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., & Bryan, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80321-9 · Cited by 692
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationMutations in the glucokinase gene of the fetus result in reduced birth weight
Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., & Ellard, S. (1998) · Nature Genetics · doi:10.1038/953 · Cited by 594
Self-citation
Cited by
Items 201–300 of 1,000
Alkorta-Aranburu, G., Carmody, D., Cheng, Y. W., Nelakuditi, V., Ma, L., Dickens, J. T., Das, S., Greeley, S. A. W., & del Gaudio, D. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.09.007 · Cited by 88
“2 and SUR1) of the ATP-sensitive potassium (KATP) channel [10–12].”
BackgroundGupta, P., Bala, M., Gupta, S. K., Dua, A., Dabur, R., Injeti, E. R., & Mittal, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.029 · Cited by 101
TCF7L2 genetic defect and type 2 diabetes
Cauchi, S., & Froguel, P. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0026-x · Cited by 97
“Identifying mutations leading to monogenic forms of diabetes has also greatly facilitated the understanding of their contribution to T2D pathophysiology [5, 6 ].”
BackgroundPrecision medicine in diabetes: an opportunity for clinical translation
Merino, J., & Florez, J. C. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13588 · Cited by 95
The Cost-Effectiveness of Personalized Genetic Medicine
Greeley, S. A. W., John, P. M., Winn, A. N., Ornelas, J., Lipton, R. B., Philipson, L. H., Bell, G. I., & Huang, E. S. (2011) · Diabetes Care · doi:10.2337/dc10-1616 · Cited by 85
“There is one report of a patient who has been stably treated with a sulfonylurea for more than 50 years since his diagnosis at age 12 weeks (3).”
BackgroundSlingerland, A. S., & Hattersley, A. T. (2005) · Annals of Medicine · doi:10.1080/07853890510007287 · Cited by 89
“This has been described in three cases associated with Q52R, V59G, and I296V mutations (44).”
BackgroundMethodSelf-citationthe United States Neonatal Diabetes Working Group, Thurber, B. W., Carmody, D., Tadie, E. C., Pastore, A. N., Dickens, J. T., Wroblewski, K. E., Naylor, R. N., Philipson, L. H., & Greeley, S. A. W. (2015) · Diabetologia · doi:10.1007/s00125-015-3593-9 · Cited by 85
“An individual case who exhibited sustained efficacy of SU over many decades provides hope that those with SU-treated KCNJ11-related diabetes may not experience the progressive loss of beta cell function that is characteristic of type 2 diabetes [22].”
BackgroundNew insights into the role of connexins in pancreatic islet function and diabetes
Farnsworth, N. L., & Benninger, R. K. P. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.035 · Cited by 89
“Over-activity of KATP channels in b-cells underlies the majority of cases of neonatal diabetes [62].”
BackgroundPermanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11
Edghill, E. L., Flanagan, S. E., & Ellard, S. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9149-x · Cited by 95
“Approximately 80% of KCNJ11 mutations and 50% of ABCC8 mutations are spontaneous, arising de novo during embryogenesis [21, 28–31].”
BackgroundInfluentialSelf-citationMasia, R., Koster, J. C., Tumini, S., Chiarelli, F., Colombo, C., Nichols, C. G., & Barbetti, F. (2007) · Diabetes · doi:10.2337/db06-1275 · Cited by 86
“Both animal and human studies now demonstrate that underexcitability can suppress insulin release and contribute to hyperglycemia and neonatal diabetes mellitus (NDM) in humans (1,2).”
BackgroundThe UGDP Controversy: thirty-four years of contentious ambiguity laid to rest
Schwartz, T. B., & Meinert, C. L. (2004) · Perspectives in Biology and Medicine · doi:10.1353/pbm.2004.0071 · Cited by 85
ATP-sensitive K channel channel/enzyme multimer: Metabolic gating in the heart
Alekseev, A. E., HODGSON, D., Karger, A. B., PARK, S., Zingman, L. V., & Terzic, A. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.02.022 · Cited by 93
“2 alter cardiac mechanical properties at rest and produce a poor myocardial response to ischemic and metabolic challenge [31], and in non-cardiac tissues are associated with disease due to deficient metabolic coupling [32,33].”
BackgroundMolecular biology of KATP channels and implications for health and disease
Akrouh, A., Halcomb, S. E., Nichols, C. G., & Sala‐Rabanal, M. (2009) · IUBMB Life · doi:10.1002/iub.246 · Cited by 103
“2 and SUR1 genes that result in altered insulin secretion in the pancreas (44, 55, 105), and none of the known polymorphisms of Kir6.”
BackgroundNew ABCC8 Mutations in Relapsing Neonatal Diabetes and Clinical Features
Vaxillaire, M., Dechaume, A., Busiah, K., Cavé, H., Pereira, S., Scharfmann, R., de Nanclares, G. P., Castano, L., Froguel, P., Polak, M., et al. (2007) · Diabetes · doi:10.2337/db06-1540 · Cited by 84
Human Genetics of Obesity and Type 2 Diabetes Mellitus: Past, Present, and Future
Ingelsson, E., & McCarthy, M. I. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.118.002090 · Cited by 81
Bonnefond, A., Philippe, J., Durand, E., Muller, J., Saeed, S., Arslan, M., Martínez, R., De Graeve, F., Dhennin, V., Rabearivelo, I., et al. (2014) · Diabetes Care · doi:10.2337/dc13-0698 · Cited by 83
Neonatal diabetes mellitus: A model for personalized medicine
Greeley, S. A. W., Tucker, S. E., Naylor, R. N., Bell, G. I., & Philipson, L. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.03.004 · Cited by 84
Many faces of monogenic diabetes
Schwitzgebel, V. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12197 · Cited by 103
Villareal, D. T., Koster, J. C., Robertson, H., Akrouh, A., Miyake, K., Bell, G. I., Patterson, B. W., Nichols, C. G., & Polonsky, K. S. (2009) · Diabetes · doi:10.2337/db09-0025 · Cited by 82
“As with 1872 DIABETES, VOL. 58, AUGUST 2009 more severe NDM, the E23K variant indirectly affects ATP sensitivity by increasing the Po,zero (Fig.”
BackgroundInfluentialOwen, K. R., & McCarthy, M. I. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.04.003 · Cited by 98
Bonnycastle, L. L., Willer, C. J., Conneely, K. N., Jackson, A. U., Burrill, C. P., Watanabe, R. M., Chines, P. S., Narisu, N., Scott, L. J., Enloe, S. T., et al. (2006) · Diabetes · doi:10.2337/db06-0178 · Cited by 81
“As mentioned earlier, this includes PPARG and KCNJ11 in type 2 diabetes (6–8).”
BackgroundGenetic Basis of Maturity-Onset Diabetes of the Young
Vaxillaire, M., & Froguel, P. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.02.009 · Cited by 85
The Human Islet: Mini-Organ With Mega-Impact
Walker, J. T., Saunders, D. C., Briššová, M., & Powers, A. C. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab010 · Cited by 97
Ketone bodies, glycolysis, and KATP channels in the mechanism of the ketogenic diet
Yellen, G. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01843.x · Cited by 79
“…then genetic contributions to efficacy—including, for instance, polymorphisms in KATP channel genes that affect the risk of diabetes, possibly due to their effect on channel open probability (Gloyn et al., 2004)—may provide additional clues to the actual mechanisms of protection in humans.”
BackgroundDifferential nucleotide regulation of K channels by SUR1 and SUR2A
Masia, R., Enkvetchakul, D., & Nichols, C. G. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.03.009 · Cited by 83
Codner, E., Flanagan, S., Ellard, S., García, H., & Hattersley, A. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.758 · Cited by 80
Self-citationCurrent status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes
Riedel, M. J., Steckley, D., & Light, P. E. (2004) · Human Genetics · doi:10.1007/s00439-004-1216-5 · Cited by 80
Shankar, R. K., Pihoker, C., Dolan, L. M., Standiford, D., Badaru, A., Dabelea, D., Rodriguez, B., Black, M. H., Imperatore, G., Hattersley, A., et al. (2012) · Pediatric Diabetes · doi:10.1111/pedi.12003 · Cited by 76
“It is possible that the misclassification occurred prior to the knowledge of NDM, since SEARCH participants identified with NDM came from the 2001–2008 cohorts, while the first KCNJ11 mutation causing neonatal diabetes was not reported until 2004 (8).”
Self-citationISPAD Clinical Practice Consensus Guidelines 2006?2007 Definition, epidemiology and classification
Craig, M. E., Hattersley, A. T., & Donaghue, K. C. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00216.x · Cited by 99
“d Permanent cases have been associated with pancreatic aplasia, activating mutations of KCNJ11, which is the gene encoding the adenosine-triphosphatesensitive potassium channel subunit Kir6.2 (7p15p13), as well as ABCC8 [sulphonylurea receptor 1 (SUR1)], also in the same chromosome region ( 57 , 58); mutations of the…”
BackgroundSelf-citationRubioCabezas, O., Flanagan, S. E., Damhuis, A., Hattersley, A. T., & Ellard, S. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00824.x · Cited by 73
Self-citationATP-Sensitive Potassium Channels — Neonatal Diabetes Mellitus and Beyond
Sperling, M. A. (2006) · New England Journal of Medicine · doi:10.1056/nejme068142 · Cited by 80
Genetic Architecture of Type 2 Diabetes: Recent Progress and Clinical Implications
Grant, R. W., Moore, A. F., & Florez, J. C. (2009) · Diabetes Care · doi:10.2337/dc08-2171 · Cited by 90
“Work on this locus has confirmed that a less drastic change in a gene implicated in a rare monogenic subtype of diabetes (12) can indeed contribute to its more common form: single nucleotide polymorphism (SNP) E23K of KCNJ11 has now been convincingly associated with type 2 diabetes.”
BackgroundFunctional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP
Proks, P., Girard, C., & Ashcroft, F. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi305 · Cited by 75
“In 10/13 patients with the V59M mutation, neonatal diabetes was accompanied by developmental delay ( 1 ,2,4); one patient with the V59G mutation had DEND syndrome (1).”
BackgroundMethodSelf-citationPermanent diabetes during the first year of life: multiple gene screening in 54 patients
the ISPED Early Diabetes Study Group, Russo, L., Iafusco, D., Brescianini, S., Nocerino, V., Bizzarri, C., Toni, S., Cerutti, F., Monciotti, C., Pesavento, R., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2094-8 · Cited by 72
“In Group 2, we found the previously described KCNJ11/V59M mutation [3, 21] in a patient with diabetes diagnosed at 220 days of life (mdiRM/3).”
Genetics of Monogenic Diabetes: Present Clinical Challenges
Misra, S., & Owen, K. R. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1111-4 · Cited by 83
Personalized Medicine in Diabetes
Malandrino, N., & Smith, R. J. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.156901 · Cited by 72
Molecular Basis of Neonatal Diabetes in Japanese Patients
Suzuki, S., Makita, Y., Mukai, T., Matsuo, K., Ueda, O., & Fujieda, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0486 · Cited by 73
“8 TNDM pUPD(6) 9 104 Macroglossia at onset 3 M 2005 0.”
BackgroundMethodInfluentialThomas, I. H., Saini, N., Adhikari, A., Lee, J. M., Kasa-Vubu, J. Z., Vázquez, D. M., Menon, R. K., Chen, M., & Fajans, S. S. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00526.x · Cited by 74
“2 subunit of the KATP channel, are thought to be the most common cause of permanent neonatal diabetes (3, 12).”
BackgroundDiabetes Presentation in Infancy: High Risk of Diabetic Ketoacidosis
Letourneau, L. R., Carmody, D., Wroblewski, K., DENSON, A. M., Sanyoura, M., Naylor, R. N., Philipson, L. H., & Greeley, S. A. W. (2017) · Diabetes Care · doi:10.2337/dc17-1145 · Cited by 77
Stančáková, A., & Laakso, M. (2016) · Endocrine development · doi:10.1159/000439418 · Cited by 82
Tarasov, A. I., Nicolson, T. J., Riveline, J.-P., Taneja, T. K., Baldwin, S. A., Baldwin, J. M., Charpentier, G., Gautier, J.-F., Froguel, P., Vaxillaire, M., et al. (2008) · Diabetes · doi:10.2337/db07-1547 · Cited by 70
“2 Mg(2) mmol/l 24 3 (5) 61 11 (10)* 95 9 (10)* 869 48 (6)* 1140 346 (6)* 0 Mg(2) mmol/l 8 1 (6) 25 5 (7)* 38 8 (8)* 17 3 (5)† 17 3 (6)†”
Sulfonylurea Treatment Before Genetic Testing in Neonatal Diabetes: Pros and Cons
Carmody, D., Bell, C. D., Hwang, J. L., Dickens, J. T., Sima, D. I., Felipe, D. L., Zimmer, C. A., Davis, A. O., Kotlyarevska, K., Naylor, R. N., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2494 · Cited by 71
Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery
Zhou, K., Pedersen, H., Dawed, A. Y., & Pearson, E. R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.51 · Cited by 78
Self-citationPharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
Florez, J. C. (2017) · Diabetologia · doi:10.1007/s00125-017-4227-1 · Cited by 72
“Constitutively activating mutations that lead to hyperactivity of this complex impair the ability of beta cells to depolarise in response to a glucose stimulus, hindering insulin secretion and causing insulin insufficiency [5, 6].”
BackgroundManagement of diabetes mellitus in infants
Karges, B., Meißner, T., Icks, A., Kapellen, T. M., & Holl, R. W. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.204 · Cited by 69
Lin, C.-W., Yan, F., Shimamura, S., Barg, S., & Shyng, S. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2852 · Cited by 76
Hypokalemia in Diabetes Mellitus Setting
Coregliano-Ring, L., Goia-Nishide, K., & Rangel, É. B. (2022) · Medicina · doi:10.3390/medicina58030431 · Cited by 82
“The relation of hypokalemia and hyperglycemia is based on the function of the ATPsensitive potassium (KATP) channel in islet cells [9].”
BackgroundRole of molecular genetics in transforming diagnosis of diabetes mellitus
Molven, A., & Njølstad, P. R. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.123 · Cited by 66
Self-citationHypotension Due to Kir6.1 Gain‐of‐Function in Vascular Smooth Muscle
Li, A., Knutsen, R. H., Zhang, H., Osei‐Owusu, P., Moreno‐Domínguez, A., Harter, T. M., Uchida, K., Remedi, M. S., Dietrich, H. H., Bernal‐Mizrachi, C., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000365 · Cited by 72
“2 GOF mutations result in pancreatic b-cell underactivity and neonatal diabetes.(9,10) In mice, deletion of Kir6.”
BackgroundKir2.1 is important for efficient BMP signaling in mammalian face development
Belus, M. T., Rogers, M. A., Elzubeir, A., Josey, M., Rose, S., Andreeva, V., Yelick, P. C., & Bates, E. A. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.02.012 · Cited by 69
Klupa, T., Edghill, E. L., Nazim, J., Sieradzki, J., Ellard, S., Hattersley, A. T., & Malecki, M. T. (2005) · Diabetologia · doi:10.1007/s00125-005-1731-5 · Cited by 67
“2, have been described in very-early-onset diabetes (<6 months) characterised by a profound impairment of insulin secretion [3].”
BackgroundSelf-citationType 2 diabetes and obesity: genomics and the clinic
Travers, M. E., & McCarthy, M. I. (2011) · Human Genetics · doi:10.1007/s00439-011-1023-8 · Cited by 77
“Infants with neonatal diabetes due to mutations in the KCNJ11 gene, conventionally treated with insulin, have typically shown substantial improvements in diabetes con- trol when oral sulfonylureas are substituted (Pearson et al. 2006; Gloyn et al. 2004).”
BackgroundPorter, J. R., & Barrett, T. G. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.030791 · Cited by 66
β‐Cell dysfunction in diabetes: a crisis of identity?
Brereton, M. F., Rohm, M., & Ashcroft, F. M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12732 · Cited by 78
“These mice express an inducible β-cell-specific activating KATP channel mutation (βV59M) that is found in patients with neonatal diabetes [14].”
BackgroundSelf-citationHyperinsulinism in mice with heterozygous loss of KATP channels
Remedi, M. S., Rocheleau, J. V., Tong, A., Patton, B. L., McDaniel, M. L., Piston, D. W., Koster, J. C., & Nichols, C. G. (2006) · Diabetologia · doi:10.1007/s00125-006-0367-4 · Cited by 72
“2[ΔN30]) with reduced ATP sensitivity (and presumably reduced glucose sensitivity) do have a severely undersecreting phenotype [31], and this appears to be the mechanism of PNDM in humans [22, 23, 43].”
BackgroundSimkin, D., Cavanaugh, E. J., & Kim, D. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.161927 · Cited by 78
“1) is a member of the two-pore domain K+ channel family, and is expressed in neurons and glial cells in various areas of the central nervous system (Bang et al. 2000; Lesage et al. 2000; Gnatenco et al. 2002; Gu et al. 2002).”
BackgroundModeling KATP channel gating and its regulation
Proks, P., & Ashcroft, F. M. (2008) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2008.10.002 · Cited by 77
Self-citationEffects of body weight and alcohol consumption on insulin sensitivity
Paulson, Q. X., Hong, J., Holcomb, V. B., & Núñez, N. P. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-14 · Cited by 69
Demirbilek, H., Arya, V. B., Özbek, M. N., Houghton, J., Baran, R. T., Akar, M., Tekeş, S., Tüzün, H., Mackay, D., Flanagan, S. E., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0852 · Cited by 66
Self-citationFocus on Kir6.2: a key component of the ATP-sensitive potassium channel
Haider, S. M., Antcliff, J. F., Proks, P., Sansom, M. S. P., & Ashcroft, F. M. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.01.007 · Cited by 75
Self-citationMoore, D., Walker, S. I., & Levin, M. (2017) · Convergent Science Physical Oncology · doi:10.1088/2057-1739/aa8548 · Cited by 63
Deconstructing Pancreas Development to Reconstruct Human Islets from Pluripotent Stem Cells
McKnight, K. D., Wang, P., & Kim, S. K. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.03.003 · Cited by 62
Shimomura, K., Girard, C. A. J., Proks, P., Nazim, J., Lippiat, J. D., Cerutti, F., Lorini, R., Ellard, S., Hattersley, A. T., Barbetti, F., et al. (2006) · Diabetes · doi:10.2337/db05-1640 · Cited by 63
Self-citationLin, Y., Bushman, J. D., Yan, F.-F., Haidar, S. R., MacMullen, C., Ganguly, A. A., Stanley, C. A., & Shyng, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708798200 · Cited by 62
Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2–SUR1 interactions
Tammaro, P., Girard, C. A. J., Molnes, J., Njølstad, P. R., & Ashcroft, F. M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600715 · Cited by 63
“All patients show an impaired insulin secretory response to glucose, and those tested respond to sulphonylureas such as tolbutamide and glibenclamide with insulin release (Gloyn et al, 2004; Sagen et al, 2004).”
BackgroundSelf-citationThe lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis
Vaxillaire, M., Bonnefond, A., & Froguel, P. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.001 · Cited by 77
Clinical Management of Women with Monogenic Diabetes During Pregnancy
Dickens, L. T., & Naylor, R. N. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0982-8 · Cited by 58
Origin of de Novo KCNJ11 Mutations and Risk of Neonatal Diabetes for Subsequent Siblings
Edghill, E. L., Gloyn, A. L., Goriely, A., Harries, L. W., Flanagan, S. E., Rankin, J., Hattersley, A. T., & Ellard, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2817 · Cited by 59
“KCNJ11 mutations are most common, accounting for 47% of PNDM (4, 5) and a few cases of TNDM (6, 7).”
BackgroundSelf-citationHansen, S. K., Nielsen, E.-M. D., Ek, J., Andersen, G., Glümer, C., Carstensen, B., Mouritzen, P., Drivsholm, T., Borch-Johnsen, K., Jørgensen, T., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1942 · Cited by 61
Walker, J. T., Haliyur, R., Nelson, H. A., Ishahak, M., Poffenberger, G., Aramandla, R., Reihsmann, C., Luchsinger, J. R., Saunders, D. C., Wang, P., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137017 · Cited by 58
Genes and type 2 diabetes mellitus
Groop, L., & Lyssenko, V. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0033-y · Cited by 71
Nielsen, L. B., Ploug, K. B., Swift, P., Ørskov, C., Jansen-Olesen, I., Chiarelli, F., Holst, J. J., Hougaard, P., Pörksen, S., Holl, R., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0756 · Cited by 62
Bowman, P., Mathews, F., Barbetti, F., Shepherd, M. H., Sanchez, J. E., Piccini, B., Beltrand, J., Letourneau, L. R., Polak, M., Greeley, S. A. W., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1520 · Cited by 63
Self-citationTonini, G., Bizzarri, C., Bonfanti, R., Vanelli, M., Cerutti, F., Faleschini, E., Meschi, F., Prisco, F., Ciacco, E., Cappa, M., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0329-x · Cited by 60
Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes
Girard, C. A. J., Shimomura, K., Proks, P., Absalom, N. L., Castaño, L. A., de Nanclares, G. P., & Ashcroft, F. M. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0112-3 · Cited by 67
Self-citationPancreatic β-cell KATP channels: Hypoglycaemia and hyperglycaemia
Bennett, K., James, C. T., & Hussain, K. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9144-2 · Cited by 71
“The majority (80%) of these mutations have arisen de novo during embryogenesis and in a few cases mosaicism has been reported [58, 59].”
InfluentialEvaluation of a target region capture sequencing platform using monogenic diabetes as a study-model
Gao, R., Liu, Y., Gjesing, A. P., Hollensted, M., Wan, X., He, S., Pedersen, O., Yi, X., Wang, J., & Hansen, T. (2014) · BMC Genetics · doi:10.1186/1471-2156-15-13 · Cited by 58
“The most frequent cause of PNDM is due to mutations in KCNJ11 or ABCC8 which encode a subunit and a modulator of the ATPsensitive potassium (KATP) channels in the pancreatic beta-cell, respectively [9].”
Steck, A. K., & Winter, W. E. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283488275 · Cited by 73
Identification of KCNJ15 as a Susceptibility Gene in Asian Patients with Type 2 Diabetes Mellitus
Okamoto, K., Iwasaki, N., Nishimura, C., Doi, K., Noiri, E., Nakamura, S., Takizawa, M., Ogata, M., Fujimaki, R., Grarup, N., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.12.009 · Cited by 60
Mohamadi, A., Clark, L. M., Lipkin, P. H., Mahone, E. M., Wodka, E. L., & Plotnick, L. P. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00548.x · Cited by 58
“Among patients with neonatal diabetes due to KCNJ11 mutations, approximately 25% of patients also have neurological features due to mutated KATP channels in muscle, nerve, and brain (7, 8).”
BackgroundIncidence of neonatal diabetes in Austria-calculation based on the Austrian Diabetes Register
Wiedemann, B., Schober, E., Waldhoer, T., Köhle, J., Flanagan, S. E., Mackay, D., Steichen, E., Meraner, D., Zimmerhackl, L., Hattersley, A. T., et al. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00530.x · Cited by 61
“2 and SUR1 of the ATP-sensitive potassium channel (KATP), are a common cause of both transient and permanent forms of NDM (3, 4, 9, 10).”
BackgroundSelf-citationAetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents
Feigerlová, E., Průhová, Š., Dittertová, L., Lebl, J., Pintérová, D., Kološtová, K., Černá, M., Pedersen, O. B., & Hansen, T. F. (2006) · European Journal of Pediatrics · doi:10.1007/s00431-006-0106-3 · Cited by 59
“This condition is known to result from defects of the KCNJ11 gene in a substantial proportion of cases [7].”
BackgroundAw, S., Koster, J. C., Pearson, W. L., Nichols, C. G., Shi, N., Carneiro, K., & Levin, M. G. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.07.011 · Cited by 66
“In the latter case, diabetes can also be associated with developmental delay and epilepsy, due to aberrant neuronal activity (Gloyn et al., 2004).”
BackgroundAbdulhadi‐Atwan, M., Bushman, J. D., Tornovsky-Babaey, S., Perry, A., Abu‐Libdeh, A., Gläser, B., Shyng, S., & Zangen, D. (2008) · Diabetes · doi:10.2337/db08-0159 · Cited by 61
Venkatachalapathy, P., Padhilahouse, S., Sellappan, M., Subramanian, T., Kurian, S. J., Miraj, S. S., Rao, M., Raut, A. A., Kanwar, R. K., Singh, J., et al. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s329787 · Cited by 80
“as well, and its rare potential polymorphism can even lead to a permanent form of neonatal diabetes.(38)”
BackgroundPrime suspect: the TCF7L2 gene and type 2 diabetes risk
Hattersley, A. T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33077 · Cited by 66
Self-citationDiagnostic screening of MODY2/GCKmutations in the Norwegian MODY Registry
Sagen, J. V., Bjørkhaug, L., Molnes, J., Ræder, H., Grevle, L., Sövik, O., Molven, A., & Njølstad, P. R. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00399.x · Cited by 57
Self-citationPermanent neonatal diabetes in an Asian infant
Porter, J. R., Shaw, N. J., Barrett, T. G., Hattersley, A. T., Ellard, S., & Gloyn, A. L. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.09.008 · Cited by 57
Self-citationGenetic Susceptibility to Type 2 Diabetes and Implications for Antidiabetic Therapy
Moore, A. F., & Florez, J. C. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.59.090706.135315 · Cited by 64
Dual role of K ATP channel C-terminal motif in membrane targeting and metabolic regulation
Kline, C. F., Kurata, H. T., Hund, T. J., Cunha, S. R., Koval, O. M., Wright, P. J., Christensen, M. D., Anderson, M. E., Nichols, C. G., & Mohler, P. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907138106 · Cited by 56
“In fact, even small changes in ATP sensitivity may produce large changes in channel activity, cell excitability, and insulin secretion (18, 34, 35).”
BackgroundAlsmadi, O. A., Al-Rubeaan, K. A., Wakil, S. M., Imtiaz, F., Mohamed, G., Al‐Saud, H., Al‐Saud, N. A., Al‐Daghri, N. M., Mohammad, S., & Meyer, B. F. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.777 · Cited by 61
“23 reported in a meta-analysis of K allele association with T2D [12].”
BackgroundIon Channels of the Islets in Type 2 Diabetes
Jacobson, D. A., & Shyng, S. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.08.014 · Cited by 65
Sarcolemmal K channels: what do we really know?
Flagg, T. P., & Nichols, C. G. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.01.005 · Cited by 65
de Wet, H., Rees, M. G., Shimomura, K., Aittoniemi, J., Patch, A., Flanagan, S. E., Ellard, S., Hattersley, A. T., Sansom, M. S. P., & Ashcroft, F. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707428104 · Cited by 55
Self-citationMechanisms of Disease: genetic insights into the etiology of type 2 diabetes and obesity
Lindgren, C. M., & McCarthy, M. I. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0723 · Cited by 63
“Mutations in several others—notably the genes KCNJ11 (potassium inwardly rectifying channel, subfamily J, member 11 gene) and ABCC8 (ATP-binding cassette, subfamily C, member 8 gene), which encode the components of the pancreatic β-cell K ATP channel—are known to result in various types of neonatal diabetes mellitus”
BackgroundSearching for maturity-onset diabetes of the young (MODY): when and what for?
Timsit, J., Saint-Martin, C., Dubois-Laforgue, D., & Bellanné-Chantelot, C. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.12.005 · Cited by 55
Kirkpatrick, C. L., Marchetti, P., Purrello, F., Piro, S., Bugliani, M., Bosco, D., de Koning, E. J. P., Engelse, M. A., Kerr-Conte, J., Pattou, F., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011053 · Cited by 52
“has been known to be a component of the ATP-sensitive potassium channel for many years, with clear implications for both insulin and glucagon secretion. Heterozygous activating point mutations in the protein have been identified in cases of permanent neonatal diabetes”
BackgroundManna, P. T., Smith, A. J., Taneja, T. K., Howell, G. J., Lippiat, J. D., & Sivaprasadarao, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066902 · Cited by 60
Phani, N. M., Guddattu, V., Bellampalli, R., Seenappa, V., Adhikari, P., Nagri, S. K., D’Souza, S. C., Gopinath, P. M., Satyamoorthy, K., & Rai, P. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107021 · Cited by 59
“A key role of ATP-sensitive potassium (KATP) channel is to control insulin secretion by glucose and to pair metabolism of glucose with electrical activity of the membrane [1].”
BackgroundCardiovascular consequences of KATP overactivity in Cantu syndrome
Huang, Y., McClenaghan, C., Harter, T. M., Hinman, K., Halabi, C. M., Matkovich, S. J., Zhang, H., Brown, G. S., Mecham, R. P., England, S. K., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121153 · Cited by 56
“2/SUR1 proteins in neonatal diabetes (43) has led to dramatically improved understanding of the pathophysiological consequences (44), as well as a revolution in therapy using KATP channel–blocking sulfonylurea drugs (45, 46).”
Background
Metadata
- Authors
- Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., Edghill, E. L., Frayling, T. M., Temple, I. K., Mackay, D., Shield, J. P. H., Sumnik, Z., van Rhijn, A., Wales, J. K. H., Clark, P., Gorman, S., Aisenberg, J., Ellard, S., Njølstad, P. R., Ashcroft, F. M., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- University of Oxford (GB)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Children's Hospital at Westmead (AU)
- University of Bergen (NO)
- National Health Service (GB)
- Salisbury District Hospital (GB)
- Sheffield Children's Hospital (GB)
- St. Luke's Hospital (GB)
- Hackensack University Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-04-29
- Volume
- 350
- Issue
- 18
- Pages
- 1838-1849
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012515461
- Cited by
- 1,137
- References
- 38
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 31 · 2023: 44 · 2022: 37 · 2021: 49 · 2020: 33 · 2019: 50 · 2018: 57 · 2017: 51 · 2016: 55 · 2015: 49 · 2014: 60 · 2013: 55 · 2012: 45
- FWCI
- 70.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- permanent neonatal diabetes, Kir6.2, KCNJ11, ATP-sensitive potassium channels, activating mutations, missense mutations, SUR1, tolbutamide, glucose-stimulated insulin secretion, developmental delay, muscle weakness, epilepsy, genetic diagnosis
- MeSH terms
- Developmental Disabilities, Diabetes Mellitus, DNA Mutational Analysis, Epilepsy, Face, Female, Heterozygote, Humans, Infant, Newborn, Islets of Langerhans, Male, Mutation, Pedigree, Sequence Analysis, DNA, Potassium Channels, Inwardly Rectifying
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.